BioCryst Pharmaceuticals Inc – Strategy, SWOT and Corporate Finance Report
- Pages: 56
- Published: April 2019
- Report Code: MLPH66540FSA
BioCryst Pharmaceuticals Inc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.
BioCryst Pharmaceuticals Inc (BioCryst) designs, optimizes and develops small molecule drugs that block key enzymes in the pathogenesis of diseases. The company focuses on the treatment of rare diseases and develops drugs for infectious diseases and hereditary Angioedemaon. It integrates disciplines of biology, crystallography, medicinal chemistry and computer modeling to discover and develop small molecule pharmaceuticals through the process known as structure-guided drug design. BioCryst’s products include peramivir injections, which consists of Rapivab, Alpivab, Rapiacta and Peramiflu for the treatment of Influenza. The company has strategic partnerships with corporate and academic institutes. BioCryst has research operations in Birmingham, Alabama and is headquartered in Durham, North Carolina, the US.
Scope
Detailed information on BioCryst Pharmaceuticals Inc required for business and competitor intelligence needs
A study of the major internal and external factors affecting BioCryst Pharmaceuticals Inc in the form of a SWOT analysis
An in-depth view of the business model of BioCryst Pharmaceuticals Inc including a breakdown and examination of key business segments
News about BioCryst Pharmaceuticals Inc, such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
Gain understanding of BioCryst Pharmaceuticals Inc and the factors that influence its strategies.Track strategic initiatives of the company and latest corporate news and actions.
Assess BioCryst Pharmaceuticals Inc as a prospective partner, vendor or supplier.
Support sales activities by understanding your customers' businesses better.
Stay up to date on BioCryst Pharmaceuticals Incs business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
Daiichi Sankyo Co Ltd
GlaxoSmithKline Plc
F. Hoffmann-La Roche Ltd
Shire Plc
Gilead Sciences Inc
Arbutus Biopharma Corp
Ionis Pharmaceuticals Inc
Mapp Biopharmaceutical Inc
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple report purchases.